Emerging studies suggest Retatru tide , a dual stimulator targeting both incretin and another hormone, appears to provide a notable development for obesity management . Initial human tests have shown impressive decreases in visceral fat , conceivably surpassing existing body composition therapies . However , additional study is required to thorough